EGFR and lung adenocarcinoma: Our study evidenced that, among the driver genetic alterations evaluated, in patients with lung adenocarcinoma the main factor that positively impacts real-life survival is the presence of an EGFR mutation in exons 18, 19 or 21, especially when associated with the absence of the T790M mutation in exon 20, no smoking history and female sex.